Author

Weifang Yu

Hebei Medical University

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Biology Disciplines

Click to filter author papers

Cancer Biology· 4

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 4 Organism:human· 4 Assay:bulk RNA-seq· 3 Research Focus:cancer & tumor microenvironment· 3 Research Focus:cell signaling & trafficking· 1 Assay:metagenomics· 1 Approach:statistical model· 1

Frequent Co-Authors

Mingda Xuan· 3 shared Shuangshuang Han· 3 shared Ting LiuiD· 3 shared Yi Si· 3 shared Kunyi LiuiD· 2 shared Bo Tian· 1 shared Guojian Zhou· 1 shared Hongfei Li· 1 shared

Activity by Year

2025-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersCancer Biology

Mingda Xuan

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Integrin beta 4 promotes colorectal cancer progression by upregulating Ezrin and activating the Wnt/β-catenin signaling pathway

Jing Wang, Yi Si, Mingda Xuan, Shuangshuang Han, Kunyi Liu, Jiao Jiao, Xiaoyan Men, Hongfei Li, Jia Wang, Ting Liu, Weifang Yu

This study identifies ITGB4 as a driver of colorectal cancer progression by upregulating Ezrin and activating the Wnt/β-catenin pathway.

International Journal of Oncology · May 19, 2026Peer-reviewedCancer Biology

INHBA promotes the progression of gastric cancer by activating MAPK signaling pathway via targeting ITGA6

Guojian Zhou, Rui Zhang, Lei Nie, Yi Si, Ting Liu, Jing Wang, Shuangshuang Han, Mingda Xuan, Weifang Yu, Jia Wang

Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · Jan 1, 2026Peer-reviewedCancer Biology

IGF2BP3 promotes the progression of gastric cancer by activating cGMP-PKG signaling pathway via targeting FBXO32

Yi Si, Bo Tian, Rui Zhang, Mingda Xuan, Kunyi Liu, Jiao Jiao, Shuangshuang Han, Hongfei Li, Yanhong Hu, Hongyan Zhao, Wenjing He, Jia Wang, Ting Liu, Weifang Yu

This study identifies IGF2BP3 as a promoter of gastric cancer progression by upregulating FBXO32 via m6A binding and activating the cGMP-PKG signaling pathway.

World Journal of Gastroenterology · Dec 10, 2025Peer-reviewedCancer Biology

RBM15 promotes lung adenocarcinoma progression and palbociclib sensitivity via m6A-mediated STIL activation and downstream cyclin D1/CDK4 signaling

Yifan Chen, Jiaojiao Zhang, Hongjuan Yue, Lihong Wang, Minghong Lv, Ling Wu, Junling Ma, Jing Wang, Weifang Yu, Ting Liu, Jia Wang

bioRxiv · Dec 7, 2025 · PreprintCancer Biology